The goal of the DNA Sequencing and High Throughput Genotyping Core is to produce high quality sequencing and genotyping data rapidly and at a reasonable cost for UNC-CH researchers using state-of-theart technologies as well as provide technical support to enhance the value of results produced at the Facility. The Core consolidates the use of expensive technologies and provides expert operators. Services include DNA sequencing, microsatellite genotyping and SNP genotyping. The Core is led by Dr. Laura Livingstone. The Core adds value to the Center by producing results at a competitve price while providing the benefits of a local resource to assist in: scientific strategies, sample preparation, sequencing through difficult regions, assistance in results interpretation, and providing software/software support for data interpretation. Two examples of themany UNC LCCC research projects that depend upon the Core are: the epigenetic regulation via methylation studies of Dr. Terry Magnuson (Cancer Genetics) and the discovery of novel oncogenes in human cancers by Dr. Channing Der (Molecular Therapeutics). Work is ongoing at the Core to add services for high throughput microsatellite and SNP genotyping (pilot studies underway). An essential LIMS system will be acquired for tracking laboratory work flow and data results for clients with funding provided by the university.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-34
Application #
7751867
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
34
Fiscal Year
2009
Total Cost
$387,177
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Shao, Wenwei; Chen, Xiaojing; Samulski, Richard J et al. (2018) Inhibition of antigen presentation during AAV gene therapy using virus peptides. Hum Mol Genet 27:601-613
Gao, Yanzhe; Kardos, Jordan; Yang, Yang et al. (2018) The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. Sci Rep 8:15304
Schaefer, Kristina N; Bonello, Teresa T; Zhang, Shiping et al. (2018) Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo. PLoS Genet 14:e1007339
Zuze, Takondwa; Painschab, Matthew S; Seguin, Ryan et al. (2018) Plasmablastic lymphoma in Malawi. Infect Agent Cancer 13:22
Wang, Jeremy R; Holt, James; McMillan, Leonard et al. (2018) FMLRC: Hybrid long read error correction using an FM-index. BMC Bioinformatics 19:50
Lee, Janie M; Abraham, Linn; Lam, Diana L et al. (2018) Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol 36:2070-2077
Shen, Hui; Shih, Juliann; Hollern, Daniel P et al. (2018) Integrated Molecular Characterization of Testicular Germ Cell Tumors. Cell Rep 23:3392-3406
Cousins, Emily M; Goldfarb, Dennis; Yan, Feng et al. (2018) Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3? and Activates WNT Signaling. Mol Cancer Res 16:333-344
Armstrong, Robin L; Penke, Taylor J R; Strahl, Brian D et al. (2018) Chromatin conformation and transcriptional activity are permissive regulators of DNA replication initiation in Drosophila. Genome Res 28:1688-1700
Hoadley, Katherine A; Yau, Christina; Hinoue, Toshinori et al. (2018) Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173:291-304.e6

Showing the most recent 10 out of 1525 publications